Company intelligence / Profile preview

Selleck Chemicals

Waltham Abbey, Essex, UKselleckchem.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Selleck Chemicals supplies over 120,000 bioactive compounds—including small molecule inhibitors/modulators—therapeutic antibodies and screening libraries used in cell signaling pathway studies. Their products are widely used by academic labs and pharmaceutical companies for preclinical research across diverse biological processes such as epigenetics, immunology/inflammation and oncology. They do not develop their own clinical pipeline but enable drug discovery through reagent supply.

Modalities: Small molecules (inhibitors and modulators)Therapeutic antibodiesPeptidesCompound librariesBioreagents and qPCR reagents
Industry: Chemicals & Materials

Drug pipeline

2 assets

KH-4-43

Pre-clinical

Indications: Ovarian cancer

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Selleck Chemicals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Selleck Chemicals.

Explore the full profile